The Kansas University Cancer Center has announced a new partner in its quest to achieve National Cancer Institute Designation.
It will work with the Leukemia & Lymphoma Society, with headquarters in White Plains, N.Y., to translate discoveries from LLS-funded researchers into clinical trials.
KU officials have said developing Phase I clinical trials, which deal with drugs being offered to humans for the first time, has been a key part of efforts to achieve designation as a National Cancer Center.
The partnership will initially bring $1.5 million from LLS to KU for the development of funded projects with the goal of moving blood cancer therapies into the development pipeline.
Comments
LJWorld.com doesn’t necessarily condone the comments here, nor does it review every post. Read our full policy. Also, read about banned accounts and harassing comments.